Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Br J Haematol ; 202(2): 379-383, 2023 07.
Article in English | MEDLINE | ID: mdl-37192755

ABSTRACT

Autologous hematopoietic stem cell transplant (ASCT) is the standard curative treatment for patients with high-risk relapsed/refractory Hodgkin lymphoma (R/R HL). The AETHERA study showed survival gain with Brentuximab Vedotin (BV) maintenance after ASCT in BV-naive patients, which was recently confirmed in the retrospective AMAHRELIS cohort, including a majority of BV-exposed patients. However, this approach has not been compared to intensive tandem auto/auto or auto/allo transplant strategies, which were used before BV approval. Here, we matched BV maintenance (AMAHRELIS) and tandem SCT (HR2009) cohorts, and observed that BV maintenance was associated with better survival outcome in patients with HR R/R HL.


Subject(s)
Hematopoietic Stem Cell Transplantation , Hodgkin Disease , Immunoconjugates , Humans , Brentuximab Vedotin , Hodgkin Disease/drug therapy , Retrospective Studies , Immunoconjugates/therapeutic use , Stem Cell Transplantation , Cohort Studies
2.
Gulf J Oncolog ; 1(23): 63-66, 2017 Jan.
Article in English | MEDLINE | ID: mdl-28272005

ABSTRACT

The purpose of this article is to report a new case of a probably radio-induced bilateral breast cancer occurred after prophylactic bilateral pulmonary irradiation in the treatment of osteosarcoma. A 42-year-old woman, treated at the age of 12 years for osteosarcoma at the right lower limb with chemotherapy (methotrexate, adriamycin and cisplatin) followed by non-conservative surgery and adjuvant radiotherapy. Eighteen years after, she developed her first breast cancer, and five years later, her second contralateral breast cancer. The patient was treated for her two non-metastatic cancers and is currently in complete remission. This publication adds to several previous publications the very probable effect of ionizing radiation in the occurrence of secondary cancers.


Subject(s)
Breast Neoplasms/etiology , Neoplasms, Radiation-Induced/etiology , Osteosarcoma/radiotherapy , Radiotherapy, Adjuvant/adverse effects , Adult , Antineoplastic Combined Chemotherapy Protocols , Cisplatin , Combined Modality Therapy , Female , Humans
3.
Ann Oncol ; 27(4): 719-24, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26787236

ABSTRACT

BACKGROUND: Most peripheral T-cell lymphoma (PTCL) patients have a poor outcome and the identification of prognostic factors at diagnosis is needed. PATIENTS AND METHODS: The prognostic impact of total metabolic tumor volume (TMTV0), measured on baseline [(18)F]2-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography, was evaluated in a retrospective study including 108 PTCL patients (27 PTCL not otherwise specified, 43 angioimmunoblastic T-cell lymphomas and 38 anaplastic large-cell lymphomas). All received anthracycline-based chemotherapy. TMTV0 was computed with the 41% maximum standardized uptake value threshold method and an optimal cut-off point for binary outcomes was determined and compared with others prognostic factors. RESULTS: With a median follow-up of 23 months, 2-year progression-free survival (PFS) was 49% and 2-year overall survival (OS) was 67%. High TMTV0 was significantly associated with a worse prognosis. At 2 years, PFS was 26% in patients with a high TMTV0 (>230 cm(3), n = 53) versus 71% for those with a low TMTV0, [P < 0.0001, hazard ratio (HR) = 4], whereas OS was 50% versus 80%, respectively, (P = 0.0005, HR = 3.1). In multivariate analysis, TMTV0 was the only significant independent parameter for both PFS and OS. TMTV0, combined with PIT, discriminated even better than TMTV0 alone, patients with an adverse outcome (TMTV0 >230 cm(3) and PIT >1, n = 33,) from those with good prognosis (TMTV0 ≤230 cm(3) and PIT ≤1, n = 40): 19% versus 73% 2-year PFS (P < 0.0001) and 43% versus 81% 2-year OS, respectively (P = 0.0002). Thirty-one patients (other TMTV0-PIT combinations) had an intermediate outcome, 50% 2-year PFS and 68% 2-year OS. CONCLUSION: TMTV0 appears as an independent predictor of PTCL outcome. Combined with PIT, it could identify different risk categories at diagnosis and warrants further validation as a prognostic marker.


Subject(s)
Lymphoma, T-Cell, Peripheral/diagnostic imaging , Lymphoma, T-Cell, Peripheral/drug therapy , Prognosis , Tumor Burden , Adult , Aged , Aged, 80 and over , Anthracyclines/administration & dosage , Disease-Free Survival , Female , Fluorodeoxyglucose F18 , Humans , Lymphoma, T-Cell, Peripheral/pathology , Male , Middle Aged , Positron Emission Tomography Computed Tomography
5.
Cancer Radiother ; 18(5-6): 509-16, 2014 Oct.
Article in French | MEDLINE | ID: mdl-25195114

ABSTRACT

Major improvements in the field of radiotherapy planning such as stereotactic radiation therapy, have recently been performed, aiming to the development of personalized therapeutic strategies in patients with biochemical failure of prostate cancer. However, this needs an early and accurate location of sites of recurrence. Development of multimodality magnetic resonance imaging (MRI) and positron emission tomography (PET) permits to consider this objective. Thus, it is worthwhile to apprehend the respective performance of these imaging techniques in order to rationalize their use. We propose a review of the recent literature organized by technique and by location, regarding the performance of multimodality MRI and PET for restaging of patients with biochemical failure of prostate cancer initially treated with curative intent.


Subject(s)
Adenocarcinoma/secondary , Magnetic Resonance Imaging/methods , Multimodal Imaging , Neoplasm Staging/methods , Positron-Emission Tomography/methods , Prostatic Neoplasms/pathology , Adenocarcinoma/blood , Adenocarcinoma/diagnostic imaging , Adenocarcinoma/therapy , Brachytherapy , Carbon Radioisotopes , Choline/analogs & derivatives , Fluorine Radioisotopes , Fluorodeoxyglucose F18 , Humans , Lymphatic Metastasis/diagnostic imaging , Male , Neoplasm Recurrence, Local/diagnostic imaging , Prostate-Specific Antigen/blood , Prostatectomy , Prostatic Neoplasms/blood , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/therapy , Radiopharmaceuticals , Salvage Therapy/methods
6.
Ann Phys Rehabil Med ; 55(3): 190-200, 2012 Apr.
Article in English, French | MEDLINE | ID: mdl-22445109

ABSTRACT

OBJECTIVE: The objective is to study the rehabilitation management and to assess autonomy in daily life activities as well as walking recovery in patients with complicated Pott's disease. PATIENTS AND METHODS: Retrospective study in nine patients over a period of 8 years extending from 2000 to 2008, collated in the Department of Physical Medicine and Functional Rehabilitation, CHU Sahloul, Sousse, Tunisia. RESULTS: The mean age of our patients was 43.8 years; sex ratio was 5/4. The spine involvement of tuberculosis was dorsal in seven cases, dorso-lumbar in one patient, and multiple (cervical, dorsal and lumbar) in one case. All patients were paraplegic with a neurological involvement of the bladder. They had prior antituberculosis chemotherapy for at least 8 months. Decompression surgery was performed in six cases. Two female patients presented disorders of spinal posture during treatment requiring surgical revision with osteosynthesis. All patients received additional rehabilitation care. Following a mean duration of hospitalisation in the Rehabilitation department of 47 days with twice-daily sessions of tailored physiotherapy, three patients remained in complete paraplegia, autonomous in wheel-chair and with vesical and sphincter incontinence. The measure of functional independence (MFI) was at admission/discharge 71/92. CONCLUSION: Rehabilitation takes an important place in the medico-surgical management in Pott's disease, to limite or compensate the disabilities and handicap related to this pathology.


Subject(s)
Paraplegia/rehabilitation , Tuberculosis, Spinal/rehabilitation , Urinary Bladder, Neurogenic/rehabilitation , Activities of Daily Living , Adult , Aged , Female , Humans , Male , Middle Aged , Paraplegia/etiology , Prognosis , Tuberculosis, Spinal/complications , Urinary Bladder, Neurogenic/etiology
7.
Cancer Radiother ; 14 Suppl 1: S127-35, 2010 Nov.
Article in French | MEDLINE | ID: mdl-21129655

ABSTRACT

Breast cancer is the most common cancer in women. In France, breast cancer incidence was 88.9 per 100,000 women in 2000. Early detection of breast tumours by screening mammography allows a breast conserving treatment, i.e., breast irradiation preceded by a lumpectomy and a sentinel node biopsy. The standard irradiation of early breast cancers consists in delivering 50 Gy to the whole breast in 2 Gy fractions over a five-week period followed by an additional dose targeting the tumour bed of 16 Gy in eight fractions. The 3D-conformal treatment planning optimizes dose distribution to the whole breast and to the tumour bed and lessens the normal tissue irradiation (heart and ipsilateral lung). The aim of this article is to describe epidemiologic, radio anatomic and prognostic features of early stage breast cancer and to propose guidelines for 3D-conformal treatment planning in early breast cancers. This review is illustrated by a case report.


Subject(s)
Breast Neoplasms/radiotherapy , Lymph Nodes/pathology , Radiotherapy, Conformal/methods , Sentinel Lymph Node Biopsy/methods , Axilla/pathology , Breast Neoplasms/epidemiology , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Carcinoma, Ductal, Breast/pathology , Carcinoma, Ductal, Breast/radiotherapy , Carcinoma, Ductal, Breast/surgery , Female , France/epidemiology , Humans , Lymph Node Excision , Lymphatic Metastasis/pathology , Mammography , Neoplasm Staging , Prognosis , Radiotherapy Dosage
8.
Cancer Radiother ; 14 Suppl 1: S136-46, 2010 Nov.
Article in French | MEDLINE | ID: mdl-21129656

ABSTRACT

Breast cancer is the most frequent cancer of women in western countries. There are one million new cases per year in the world which represents 22% of all female cancers, and more than 370,000 deaths due to breast cancer per year (14% of cancer mortality). More than half of breast cancers are associated with axillary nodal involvement. Post-operative radiation therapy (XRT) is a crucial part of locoregional treatment in axillary nodal involvement breast cancer owing to a 15-years risk reduction of locoregional recurrence of 70% and to a 5.4% risk reduction of specific mortality. In 3D-conformal irradiation in such breast cancers, target volumes are chest wall when mastectomy was performed or breast and boost of tumor bed in case of breast conservative surgery, and supra-clavicular and/or axillary and/or internal mammary node areas. The main organs at risk are ipsilateral lung, heart and brachial plexus. The aim of this article is to describe epidemiologic, radio anatomic and prognostic features of axillary nodal involvement breast cancer and to propose guidelines for 3D-conformal treatment planning in locally advanced breast cancers. This review is illustrated by a case report.


Subject(s)
Breast Neoplasms/pathology , Breast Neoplasms/radiotherapy , Lymphatic Metastasis/pathology , Radiotherapy, Conformal/methods , Breast Neoplasms/epidemiology , Breast Neoplasms/mortality , Breast Neoplasms/surgery , Combined Modality Therapy , Female , Humans , Incidence , Lymph Nodes/pathology , Lymph Nodes/surgery , Mastectomy , Survival Rate
9.
Cancer Radiother ; 12(6-7): 522-6, 2008 Nov.
Article in French | MEDLINE | ID: mdl-18951823

ABSTRACT

Even if the prognosis of patients with cervical cancer has been dramatically improved with concomitant chemoradiation, brachytherapy still plays fundamental role in the therapeutic approach of patients with Figo stage I-IV cervical carcinoma. The development of imaging with three-dimensional dosimetry has contributed to the improvement in target and organs at risk knowledge. In 2005 and 2006, GEC-ESTRO recommendations on 3-D based image brachytherapy have defined the different volumes of interest. These recommendations have been validated with intercomparison delineation studies. Data on dose to normal tissues are better known with dose volume-histograms analysis. Dose limits to the bladder are high in the range of 90 Gy to the 2 cm3 while 2 cm3 limits to the rectum do not differ from ICRU point. The sigmoid is currently under study as this organ was not extensively studied before the era of imaging. Doses to the tumour (HR-CTV or IR-CTV) are not clearly stated and will likely depend on tumour extension.


Subject(s)
Brachytherapy/methods , Uterine Cervical Neoplasms/radiotherapy , Brachytherapy/adverse effects , Brachytherapy/standards , Diagnostic Imaging , Female , Humans , Radiography , Radiometry , Radiotherapy Dosage , Rectum/radiation effects , Urinary Bladder/radiation effects , Uterine Cervical Neoplasms/diagnostic imaging , Uterine Cervical Neoplasms/pathology
10.
J Chromatogr ; 376: 259-67, 1986 Apr 11.
Article in English | MEDLINE | ID: mdl-3086352

ABSTRACT

We propose a new affinity sorbent, matrix-linked histidine, for the large-scale purification of proteins. A variety of proteins and certain peptides, each distinct from the other, were purified. Immunoglobulin G from human placenta was chosen for a detailed study concerning the effects of coupling, spacer-arm and other parameters. Multiple interactions such as charge-transfer and other ionic reactions have been suggested to be responsible for the interactions between proteins and ligand.


Subject(s)
Proteins/isolation & purification , Serine Endopeptidases , Animals , Carboxypeptidases/isolation & purification , Cathepsin A , Cattle , Chick Embryo , Chymosin/isolation & purification , Endopeptidases/isolation & purification , Female , Histidine/isolation & purification , Humans , Immunoelectrophoresis , Immunoglobulin G/isolation & purification , Peptides/isolation & purification , Placenta/analysis , Pregnancy , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae Proteins , Sepharose/analogs & derivatives , Sepharose/isolation & purification , Spectrophotometry, Ultraviolet
SELECTION OF CITATIONS
SEARCH DETAIL
...